CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 4 Open-market buy Director bought 6,000 shares at $6.64 ($39,867)
- 8-K Event Other events
- 4 Open-market buy Director bought 15,000 shares at $6.93 ($104,018)
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market buy Chief Executive Officer bought 6,000 shares at $7.50 ($45,000)
- 4 Open-market buy Director bought 25,000 shares at $7.50 ($187,500)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $7.50 ($7,500)
- 4 Open-market buy Director bought 10,000 shares at $7.50 ($75,000)
- 4 Open-market buy Director bought 6,000 shares at $7.50 ($45,000)
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- 4 Open-market buy Chief Medical Officer bought 4,500 shares at $8.38 ($37,710)
Page 59 of 76 · 1,519 filings